Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Related Keywords

Rhui Zhou ,Guangdong ,China ,Taiwan ,Shanghai ,United States ,Hong Kong ,Zhejiang ,Suzhou ,Jiangsu ,Macau ,American ,Innovent Biologics ,Adimab Incyte ,Caicun Zhou ,Eli Lilly ,School Of Medicine ,American Society Of Clinical Oncology ,Prnewswire Innovent Biologics Inc ,Md Anderson Cancer Center ,Zhejiang University ,Innovent Or Company ,Incyte Corporation ,Innovent Biologics Inc ,Clinical Oncology ,Annual Meeting ,Phase Ib Proof Of Concept ,Shanghai Pulmonary Hospital ,First Affiliated Hospital ,Senior Vice President ,Main Board ,Stock Exchange ,Hong Kong Limited ,Cancer Center ,Mainland China ,